Should I buy Omega Healthcare Investors (OHI) stock or is it too late?
⭐ The most reliable of them, either direction: Cantor Fitzgerald — 63% of its targets hit on this sector (8 calls tested). It aims for $56 (+21 %), call made on August 1, 2026, maturing on August 1, 2027 (27 d ago).
Firm-by-firm track record on Omega Healthcare Investors
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Wells Fargo | 78 % | +10.2 % | 9 | $49 +6% |
| B of A Securities | 50 % | -7.5 % | 6 | $46 -1% |
| Raymond James | 53 % | +7.4 % | 15 | — |
✅ Reasons to believe
- Pays a dividend (5.6% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- Even the most reliable firm on OHI, Mizuho (100% hit rate, 2 scored calls), only targets $40 (call made on September 11, 2025, maturing on September 11, 2026) (-14%) in its most recent call. The stock may already have run past its target.
- The consensus is not unanimous: of 9 ratings, 4 are neutral and 2 are sells.
- Limited upside: the median target is only +6% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on OHI
Median target $49 (+6%) · 9 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Omega Healthcare Investors now?
We won't decide for you. The facts: 33% of analysts rate it a buy, median target $49 (+6%), and Mizuho (most reliable on OHI, 100%) targets $40. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Omega Healthcare Investors?
Not according to analysts: the median target ($49) is still +6% above the current price ($46) (most reliable on OHI: Mizuho, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Omega Healthcare Investors still worth investing in?
It depends on the gap between the price ($46) and its estimated value: analysts target $49 on median (+6%), with 33% buys (most reliable on OHI: Mizuho, 100%). Cross-check with their real reliability on OHI and the cautions above. Information, not advice.
What's the main risk in buying OHI?
Even the most reliable firm on OHI, Mizuho (100% hit rate, 2 scored calls), only targets $40 (call made on September 11, 2025, maturing on September 11, 2026) (-14%) in its most recent call. The stock may already have run past its target.
→ Go deeper: the full Omega Healthcare Investors profile (consensus, analyst reliability, price target, performance).